Maplelane Capital’s Cognex CGNX Stock Holding History

Maplelane Capital’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-300,000	Closed	-$16.8M	–	91
2019 Q4	$16.8M	Buy	+300,000	New	+$15.5M	0.45%	60

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Maplelane Capital's CGNX Position: Q4 2021 in Review

Maplelane Capital sold out of Cognex (CGNX) in Q4 2021, closing a stake of 25,000 shares — an estimated $2M sold.

Maplelane Capital first reported a position in CGNX in Q3 2013 and held it in 9 quarters. The position peaked at $11.1M in Q4 2019. 539 funds tracked by Wall St. Rank hold CGNX as of Q4 2021.

Maplelane Capital reported no remaining Cognex position as of Q4 2021 after selling out during the quarter.
Maplelane Capital sold 25,000 Cognex shares in Q4 2021, an estimated $2M.
Maplelane Capital first reported a position in Cognex in Q3 2013 and held it in 9 quarters.
Maplelane Capital's Cognex position peaked at $11.1M in Q4 2019.
539 funds tracked by Wall St. Rank held Cognex as of Q4 2021.

Based on Maplelane Capital's 13F filing for Q4 2021, filed 14 Feb 2022.